The Accelerating Clinical Trials (ACT) Canada Consortium, a group of 28 leading Canadian research institutions, has a mission to elevate Canadian clinical trials to a new standard of global excellence.

The ACT Consortium has received $39 million in new funding for clinical trials from the Canadian Institute for Health Research (CIHR), over 3 years.

Cloud DX is invited to speak at the First Annual ACT Canada Consortium Conference, addressing up to 300 Canadian researchers who can access funds for new clinical studies.

Neil Fraser, board member and former President of Medtronic Canada will deliver a briefing on Cloud DX virtual care technology to assembled researchers at 9:25 AM on April 17th, 2023.

Cloud DX has a successful track record of collaboration with North American and European academic researchers including Population Health Research Institute (PHRI), a leading ACT institution.

The Company is currently involved in clinical trials alongside Medtronic Canada, with $5.6 million in funding from the Digital Supercluster, and in 3 studies with PHRI funded by CIHR. Cloud DX expects to receive up to $930,000 CAD in direct non-dilutive funding in the next 12 months.

Since inception, Cloud DX and its academic partners have received over $24 million CAD in non-dilutive funding for studies that validate Cloud DX Connected Health technologies.

Published, peer reviewed papers detailing Cloud DX Connected Health benefits include:

• A Comparison and Calibration of a Wrist-Worn Blood Pressure Monitor for Patient Management: Assessing the Reliability of Innovative Blood Pressure Devices. CCV-1 Catheter Study, JMIR April 2018
• Post-discharge after surgery Virtual Care with Remote Automated Monitoring-1 (PVC-RAM-1) Technology versus Standard Care: Randomized Controlled Trial. BMJ 2021:374:n2209 Sept 2021
• A Novel Hospital-to-Home System for Children with Medical Complexities: Usability Testing Study. Formative.JMIR Aug 2022.

The First Annual ACT Canada Consortium Conference will be held at the Hamilton Convention Centre in Hamilton, ON, CA on April 17th-18th, 2023.